2Haddad B,Deis S,Goffinet F,et al.Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation[J].Am J Obstet Gyneco1,2004,190:1590-1597
2Branch DW, Andres R, Digre KB, et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol, 1989,73:541-545.
3Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol,1994,171:818-822.
4Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onest, severe pre-eclampsia: maternal outcome. BJOG ,2000,107:1252-1257.
5Cunningham FC, Gant NF, Leveno KJ, eds. Williams Obstetrics. 21st ed. New York: McGraw-Hill ,2001. 569-570.
6Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?Am J Obstet Gynecol, 1999,180:221-225.
7Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol,1998,179:1632-1639.
8Hall DR, Odendaal HJ, Kirsten GF, et al. Expectant management of early onest, severe pre-eclampsia: perinatal outcome. BJOG,2000,107:1258-1264.
9Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol, 1990, 76:1070-1075.
